Published 2 months ago

Ozempic and Wegovy could double as kidney disease treatment, study suggests

The FLOW study involved 3,533 patients and showed a 24% decrease in kidney disease progression and cardiovascular and kidney death after 3.4 years.
Patients treated with semaglutide had slower kidney function decline, 18% lower risk of major cardiovascular events, and 20% lower risk of death compared to those on a placebo.
Semaglutide use in type 2 diabetes patients with chronic kidney disease reduces major kidney outcomes and risk of cardiovascular events, as stated by Perkovic.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Reuters

Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial

Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of kidney failure, heart problems, stroke and death, according to detailed results from a late-stage trial presented on Friday.

2 months ago·United Kingdom

Read Full Article

CNN

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and chronic kidney disease, according to a new study.

2 months ago·Atlanta, United States

Read Full Article

KRDO

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

By Deidre McPhillips, CNN (CNN) — Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and chronic kidney disease, according to a new study. Diabetes is a key risk factor for kidney disease, which is one of the leading causes of death in the United States and worldwide; about 1 in 3 people with diabetes also …

2 months ago·Colorado Springs, United States

Read Full Article

KIFI

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

2 months ago·Idaho Falls, United States

Read Full Article

The Washington Post

Ozempic cuts risk of death from kidney disease, major study finds

Novo Nordisk will seek FDA approval to dramatically expand the number of patients eligible for the shots.

2 months ago

Read Full Article

Globo

Innovative study shows that Ozempic reduces the risk of chronic kidney disease and diabetes complications

Important clinical trial showed promising results that the drugmaker of the medicine stopped it prematurely. Semaglutide, the compound present in the highly successful Ozempic and Wegovy medicines, dramatically reduced the risk of kidney complications, heart problems, and death in people with type 2 diabetes and chronic kidney disease in an important clinical trial, whose results were published on Friday. The discoveries could change the way doc…

2 months ago·Brazil

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources0

Leaning Left5Leaning Right3Center40Last Updated2 months agoBias Distribution

83% Center

Bias Distribution

83% of the sources are Center

84% Center

+35

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Ozempic and Wegovy could double as kidney disease treatment, study suggests

0 Articles

0 Articles

Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial

Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds

Ozempic cuts risk of death from kidney disease, major study finds

Ozempic cuts risk of death from kidney disease, major study finds

Innovative study shows that Ozempic reduces the risk of chronic kidney disease and diabetes complications

Innovative study shows that Ozempic reduces the risk of chronic kidney disease and diabetes complications

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics